fda semaglutide compounding warning november 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compounding GLP-1 Drugs - Recent

Contraindications L-carnitine is not recommended or requires medical advice in the following situations: Severe chronic kidney disease (accumulated TMAO) Unbalanced hypothyroidism (possible interference) Epilepsy : neurological advice necessary (varies by case) Pregnant or nursing women : as a precaution, insufficient data Children : except for specific medical prescription Known allergy to one of the components Drug interactions Seek medical advice before supplementation if you are taking: Anticoagulants (warfarin, AVK) : L-carnitine may potentiate anticoagulant effect INR monitoring Thyroid hormones (levothyroxine): possible interaction Antiepileptic drugs (valproic acid): to be discussed with your neurologist Chemotherapy : oncology consultation essential In case of serious chronic disease or regular medication use, consult your doctor before starting a course

This observation suggests a possible relationship with the body's adjustment period to the medication, though this pattern has not been formally studied

While these bigger-picture issues are important, they will take a lot of time and political will to change

Finally, patients should ask about what to do if side effects occur